10x Genomics Inc’s recently made public that its Chief Executive Officer Saxonov Serge unloaded Company’s shares for reported $84393.0 on Feb 28 ’25. In the deal valued at $10.63 per share,7,942 shares were sold. As a result of this transaction, Saxonov Serge now holds 871,540 shares worth roughly $6.51 million.
Then, Serge Saxonov bought 7,942 shares, generating $83,947 in total proceeds.
Before that, Hindson Benjamin J. sold 4,573 shares. 10x Genomics Inc shares valued at $50,603 were divested by the insider at a price of $11.07 per share. As a result of the transaction, Hindson Benjamin J. now holds 335,324 shares, worth roughly $2.5 million.
Leerink Partners downgraded its 10x Genomics Inc [TXG] rating to a Market perform from a an Outperform in a research note published on February 13, 2025; the price target was decreased to $12 from $25. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early September with a ‘”an Outperform”‘ rating. Jefferies also remained covering TXG and has increased its forecast on July 22, 2024 with a “Buy” recommendation from previously “Hold” rating. JP Morgan revised its rating on July 18, 2024. It rated TXG as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of TXG
On Friday, 10x Genomics Inc [NASDAQ:TXG] saw its stock fall -6.27% to $7.47. Over the last five days, the stock has lost -18.45%. 10x Genomics Inc shares have fallen nearly -47.98% since the year began. Nevertheless, the stocks have fallen -79.45% over the past one year. While a 52-week high of $37.74 was reached on 01/13/25, a 52-week low of $7.94 was recorded on 04/04/25. SMA at 50 days reached $11.46, while 200 days put it at $16.40.
Levels Of Support And Resistance For TXG Stock
The 24-hour chart illustrates a support level at 7.18, which if violated will result in even more drops to 6.88. On the upside, there is a resistance level at 7.77. A further resistance level may holdings at 8.07. The Relative Strength Index (RSI) on the 14-day chart is 25.11, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.01%. Stochastics %K at 7.56% indicates the stock is a buying.
How much short interest is there in 10x Genomics Inc?
A steep rise in short interest was recorded in 10x Genomics Inc stocks on 2025-03-14, growing by 0.76 million shares to a total of 12.08 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 11.32 million shares. There was a rise of 6.29%, which implies that there is a positive sentiment for the stock.
